DVAX Stock Forecast: High-risk Player Amidst Potential COVID Vaccine

The Tesla stock forecast was written by Hugh Camiener, Analyst at I Know First. Bachelor of Arts candidate at Columbia University.

Summary

  • Dynavax is a commercial state biopharmaceutical company which develops and commercializes vaccines..
  • Dynavax has an FDA approval on their Hepatitis B vaccine, and they have partnered with Sinovac in developing a vaccine for COVID. 
  • The pandemic has caused a significant decline in Dynavax’s revenue, with their net product revenue falling 71% in comparison to Q2 last year.
  • Dynavax’s vaccine partnership with Sinovac has shown positive signs in phase 1 and phase 2 of testing, and their vaccine will be entering phase 3 in Brazil.
  • There is a large amount of volatility in the biopharmaceutical industry; amidst Russia’s self-proclaimed vaccine, Dynavax’s stock fell 9.7%.
  • Dynavax stock forecast remains a high-risk, high reward option..

Read The Full Premium Article

Subscribe to receive exclusive PREMIUM content Here

DVAX Stock Forecast: Table Is Being Set – Revenue Growth Is On The Way

 

The article was written by Amber Zhou, a Financial Analyst at I Know First.

DVAX Stock Forecast

“We believe there’s a great opportunity for Dynavax to contribute to the overall health of the adult population with diabetes”—said Dr. Rob Janssen, chief medical officer of Dynavax.

(Source: mmm-online.com)

 

Highlights:

  • Competitive Edge and Huge Market Potential from Heplisav-B®
  • Market Doubts about Trial Data of Immuno-Oncology Platform
  • Strong Cash Position from Debt Financing
  • Current I Know First Bullish Forecast For DVAX

premiumRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content here

Dynavax Stock Analysis: Low Risk and High Reward, Buy Now.

  The article was written by Moises Meir, a Financial Analyst at I Know First

Dynavax Stock Analysis: Low Risk and High Reward, Buy Now.

Summary

  • Dynavax has an upcoming product that will revolutionize the vaccine industry./li>
  • When is HEPLISAV-B's launch?
  • Other current projects at DVAX
  • Financial/Stock Performance & I Know First's Bullish Forecast

Outlook For Gold PricesRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content Here